Literature DB >> 25468232

Palliative and supportive care for glioma patients.

Tobias Walbert1, Kristen Chasteen.   

Abstract

The diagnosis of a brain tumor is a life-changing event for patients and families. High-grade gliomas are incurable and long-term survival remains limited. While low-grade glioma patients have better outcomes, their quality of life is often affected by a variety of symptoms as well. Helping glioma patients improve quality of life at all stages of illness is an important goal for the interdisciplinary care team. There is evidence from advanced lung cancer patients that early involvement of a palliative care team can improve patient's quality of life, symptom burden, and even survival and a similar approach benefits glioma patients as well. Patients with high-grade and low-grade glioma often suffer from significant symptom burden. We discuss how validated global symptom assessments and symptom-specific screening tools are useful to identify distressing symptoms. Seizures, fatigue, depression, and anxiety are some of the more common symptoms throughout the disease course and should be managed actively. Patients with glioma also have high symptom burden at the end of life and the majority lose decision-making capacity. Advance care planning conversations early in the disease course are essential to elicit the patient's wishes for end of life care and effective communication with surrogate decision makers during all stages of the disease helps ensure that those wishes are respected.

Entities:  

Mesh:

Year:  2015        PMID: 25468232     DOI: 10.1007/978-3-319-12048-5_11

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  14 in total

1.  The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.

Authors:  Yu Zhu; Anmin Liu; Xuebin Zhang; Lisha Qi; Ling Zhang; Jing Xue; Yi Liu; Ping Yang
Journal:  Tumour Biol       Date:  2014-12-28

Review 2.  Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016.

Authors:  Marom Bikson; Pnina Grossman; Chris Thomas; Adantchede Louis Zannou; Jimmy Jiang; Tatheer Adnan; Antonios P Mourdoukoutas; Greg Kronberg; Dennis Truong; Paulo Boggio; André R Brunoni; Leigh Charvet; Felipe Fregni; Brita Fritsch; Bernadette Gillick; Roy H Hamilton; Benjamin M Hampstead; Ryan Jankord; Adam Kirton; Helena Knotkova; David Liebetanz; Anli Liu; Colleen Loo; Michael A Nitsche; Janine Reis; Jessica D Richardson; Alexander Rotenberg; Peter E Turkeltaub; Adam J Woods
Journal:  Brain Stimul       Date:  2016-06-15       Impact factor: 8.955

3.  Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.

Authors:  Lixia Wang; Xiantao Ye; Xingming Cai; Jingna Su; Renqiang Ma; Xuyuan Yin; Xiuxia Zhou; Huabin Li; Zhiwei Wang
Journal:  Oncotarget       Date:  2015-07-20

4.  Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells.

Authors:  Xue Wang; Jiaojiao Deng; Jinxia Yuan; Xin Tang; Yuelong Wang; Haifeng Chen; Yi Liu; Liangxue Zhou
Journal:  Int J Oncol       Date:  2017-06-08       Impact factor: 5.650

5.  Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells.

Authors:  Jia Ouyang; Hui Xu; Ming Li; Xingliang Dai; Fengqing Fu; Xueguang Zhang; Qing Lan
Journal:  Oncol Rep       Date:  2017-12-28       Impact factor: 3.906

6.  Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial.

Authors:  Florien W Boele; Martin Klein; Irma M Verdonck-de Leeuw; Pim Cuijpers; Jan J Heimans; Tom J Snijders; Maaike Vos; Ingeborg Bosma; Cees C Tijssen; Jaap C Reijneveld
Journal:  J Neurooncol       Date:  2017-12-13       Impact factor: 4.130

7.  Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy.

Authors:  Vijay M Patil; Nikhil Pande; Arun Chandrasekharan; Chandrakanth M; Raees Tonse; Rahul Krishnatry; Jayant S Goda; Hollis Dsouza; Dilip Harindran Vallathol; Santam Chakraborty; Tejpal Gupta; Rakesh Jalali
Journal:  CNS Oncol       Date:  2018-04-30

8.  I-CoPE: A pilot study of structured supportive care delivery to people with newly diagnosed high-grade glioma and their carers.

Authors:  Jennifer Philip; Anna Collins; Jane Staker; Michael Murphy
Journal:  Neurooncol Pract       Date:  2018-05-19

9.  MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.

Authors:  Jian-Jun Gu; Jian-He Zhang; Hong-Jie Chen; Shou-Sen Wang
Journal:  Int J Mol Med       Date:  2016-04-27       Impact factor: 4.101

10.  Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells.

Authors:  Lixia Wang; Yingying Hou; Xuyuan Yin; Jingna Su; Zhe Zhao; Xiantao Ye; Xiuxia Zhou; Li Zhou; Zhiwei Wang
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.